Early-stage venture capital firm Lavni Ventures has announced the final close of its second deep-tech impact fund, securing its target corpus of Rs 200 crore, approximately $21 million, in committed capital. The closing arrives about a year after Fund II's first close in August 2025. The fund also retains a green-shoe option of Rs 100 crore, which could increase its overall size if exercised.
Fund Closure and Structure
Fund II follows a fully invested first fund and is built on the belief that Indian deep-tech founders can create globally scalable health and climate solutions in a capital-efficient manner. The fund is structured as a scheme of Lavni Ventures Trust, a SEBI-registered Category II Alternative Investment Fund. Its additional green-shoe option gives the firm room to back promising companies as they progress.
First Investments from Fund II
Lavni Ventures has already made its first three investments from the new fund. The portfolio includes Padcare Labs, which focuses on recycling sanitary waste, Monitra Healthcare, which builds remote cardiac monitoring devices, and Vidcare, which develops portable at-home diagnostic tests. These early commitments reflect the firm's continued hands-on and long-term partnership approach first established through Fund I.
Deployment Strategy and Ticket Sizes
With the target corpus now committed, the firm's focus shifts to deployment and identifying exceptional founders across India. Fund II invests in foundational health and climate technologies with initial checks ranging from Rs 2 crore to Rs 6 crore, or about $210,000 to $630,000, at the seed stage. The fund also plans follow-on investments of Rs 8 crore to Rs 15 crore, roughly $850,000 to $1.5 million, for fresh Series A rounds and later stages.
Why Patient Capital Matters
Deep-tech startups often require more patient capital because product testing, regulatory approvals, and market adoption can take significant time. Unlike many software ventures, companies building medical devices, diagnostics, or climate systems may need clinical trials and field validation before scaling. The fund's structure is designed to support these longer development cycles through both early and follow-on investments.
Focus on Health and Climate Founders
Lavni Ventures was founded in 2020 with a focus on early-stage deep-tech companies working on health and climate solutions. The investment approach rests on the view that Indian founders can develop technology-driven products for global markets without requiring excessive capital. By concentrating on foundational technologies, the firm seeks practical advances in healthcare delivery, medical monitoring, diagnostics, and environmental challenges.
Market Context and Ecosystem Implications
The final close of Fund II adds to a growing pool of Indian deep-tech investors that includes firms such as Speciale Invest, pi Ventures, and Ideaspring Capital. This expansion is significant because early-stage funding remains a challenge for founders whose products involve hardware, science, and longer validation timelines. More patient capital can help bridge the gap between early invention and real commercial growth in health and climate technology.
The closing of Lavni Ventures Fund II strengthens the firm's ability to back transformative ventures at a critical stage. With committed capital and a clear follow-on strategy, the firm is positioned to support founders through multiple phases of growth. As India's deep-tech ecosystem matures, sector-focused patient capital will likely play an increasingly important role in building globally relevant companies.